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Colorectal cancer (CRC) is among the leading causes of cancer deaths and can be caused by environmental factors as well as 
genetic factors. Therefore, we developed a prediction model of CRC using genetic risk scores (GRS) and evaluated the effects 
of conventional risk factors, including family history of CRC, in combination with GRS on the risk of CRC in Koreans. This study 
included 187 cases (men, 133; women, 54) and 976 controls (men, 554; women, 422). GRS were calculated with most 
significantly associated single-nucleotide polymorphism with CRC through a genomewide association study. The area under 
the curve (AUC) increased by 0.5% to 5.2% when either counted or weighted GRS was added to a prediction model consisting 
of age alone (AUC 0.687 for men, 0.598 for women) or age and family history of CRC (AUC 0.692 for men, 0.603 for women) 
for both men and women. Furthermore, the risk of CRC significantly increased for individuals with a family history of CRC in 
the highest quartile of GRS when compared to subjects without a family history of CRC in the lowest quartile of GRS (counted 
GRS odds ratio [OR], 47.9; 95% confidence interval [CI], 4.9 to 471.8 for men; OR, 22.3; 95% CI, 1.4 to 344.2 for women) 
(weighted GRS OR, 35.9; 95% CI, 5.9 to 218.2 for men; OR, 18.1, 95% CI, 3.7 to 88.1 for women). Our findings suggest that 
in Koreans, especially in Korean men, GRS improve the prediction of CRC when considered in conjunction with age and family 
history of CRC.
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Introduction
Colorectal cancer (CRC), also called colon cancer or large 
bowel cancer, includes cancerous growths in the colon, 
rectum, and appendix [1]. With 655,000 deaths worldwide 
per year, it is the fourth most common form of cancer in the 
United States (US) and the third leading cause of 
cancer-related deaths in the western world [1, 2]. In Korea, 
CRC is one of the most commonly diagnosed cancers, and its 
incidence is now dramatically increasing with the westerni-
zation of lifestyles [3]. According to statistics for Korea, the 
incidence of CRC was 9.8 per 100,000 men and 10.4 per 
100,000 women from 1999-2001 [4]. These incidence rates 
for CRC increased to 18.2 per 100,000 men and 13.7 per 
100,000 women in 2003 [5].
Given the high incidence of CRC and its significant cost to 
society, the ability to accurately predict the possibility of 
developing the disease using identifiable risk factors may 
help both physicians and patients prevent its occurrence [6]. 
Numerous studies have identified risk factors related to 
CRC, such as age, sex, family history of CRC, smoking, 
physical activity, aspirin/nonsteroidal anti-inflammatory 
drug (NSAID) use, vegetable intake, body mass index (BMI), 
alcohol consumption, and hormone replacement therapy by 
women [7-10]. 
Recently, there have been a number of studies that 
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developed a risk score or a prediction model of certain 
diseases, such as coronary heart disease (CHD) and cancers, 
using these identified risk factors [11, 12]. However, these 
risk scores or prediction models have excluded genetic risk 
factors. Genetic polymorphisms contributing to certain 
disease incidences, such as CHD, could be one type of 
emerging risk factor under investigation in studies generally 
focused on a priori selected candidate genes [13, 14]. 
Advances in genome technologies have made it possible to 
genotype and evaluate many single-nucleotide polymor-
phisms (SNPs) throughout the human genome to identify 
novel disease susceptibility genes [15]. 
A CRC prediction model has been developed in a previous 
study that estimates the probability of developing CRC, 
given a specific age, risk factor profile, and time period in 
white men and women aged 50 years and older [16]. 
However, genetic polymorphisms have not been included in 
the study. Another prediction model, developed among 
middle-aged Japanese men, included conventional risk 
factors without genetic risk factors [17]. A recent study 
developed a prediction of CHD risk, aggregating information 
from multiple SNPs into a single genetic risk score (GRS) 
and determined an improvement in the prediction of 
incident CHD in the Atherosclerosis Risk in Communities 
(ARIC) study [18]. 
From recent studies, several SNPs that may play an 
important role in triggering CRC have been introduced by a 
genome-wide association study (GWAS) among whites, 
Japanese, and Chinese but not Koreans [19-22]. Moreover, 
prediction models that were developed recently were 
performed among whites and the Japanese population [16, 
17]. Previous studies have shown that combining multiple 
loci with modest effects into a global GRS might improve the 
identification of persons who are at risk for common 
complex diseases [23-25]. Therefore, in this study, we 
intended to describe a GRS by aggregation of multiple SNPs 
contributing to CRC through a GWAS. Furthermore, we 
aimed to develop a prediction model consisting of conven-
tional risk factors as well as a genetic risk factor, such as GRS, 
in Koreans in the Korean Cancer Prevention Study-II 
(KCPS-II). 
Methods
Study population
The initial study population included 200,595 individuals, 
20-77 years of age, who visited 16 health promotion centers 
nationwide from April 2004 to December 2007 in the 
KCPS-II. Of these, there were 325 confirmed cases of CRC 
[26], but 132 cases ≥55 years of CRC onset age were 
excluded to obtain early-onset CRC cases. For controls, they 
were recruited from the Korean Metabolic Syndrome 
Research Initiative study, a part of KCPS-II, in Seoul, 
initiated in December 2005. A total of 9,128 individuals were 
recruited in 2006, and an additional 17,569 individuals were 
recruited in 2007. Therefore, the total Seoul cohort included 
26,697 volunteers. Volunteers from the first round had 
routine health examinations at the Health Promotion Center 
in university hospitals between January 2006 and December 
2007. From this total, 1,004 individuals were genotyped 
using Affymetrix Genomewide Human SNP Array 5.0 
(Affymetrix, Santa Clara, CA, USA). However, 10 of 1,004 
individuals were removed because of low genotyping call 
rates (＜95%), and 4 individuals were shown to have 
biological relatives; so, one member of each pair was 
excluded. Eleven and 2 individuals were also excluded as a 
result of gender mismatches [27]. An additional 6 cases and 
1 control were excluded due to missing anthropometric 
measurements (height, weight, BMI, waist circumstance 
[WC], and blood pressure [BP]) and self-reported que-
stionnaire information (smoking status and alcohol con-
sumption). A detailed description of the KCPS-II study 
design and methods of selection of controls in this study are 
published elsewhere [27]. Therefore, a total of 1,163 
participants (men, 687; women, 476) were included in this 
study: 187 cases (men, 133; women, 54) and 976 controls 
(men, 554; women, 422). A written consent form was signed 
by all study participants, and the Institutional Review Board 
of Yonsei University approved the study protocol. 
Genotyping
DNA samples were isolated from the peripheral blood of 
participants and genotyped using Affymetrix Genomewide 
Human SNP Array 5.0 (Affymetrix Inc.) at DNA Link Inc. 
(Seoul, Korea). Internal quality control (QC) measures were 
employed to ensure accuracy of the data. The QC call rate 
(dynamic model algorithm) was ≥95%, and heterozygosity 
of X chromosome markers identified the gender for each 
sample. Genotype calling was performed by Birdseed (v2) 
algorithm. Chromosome Y was not analyzed. A total of 1,163 
individuals were genotyped via this platform in the analysis. 
PLINK (v1.07) was used to estimate identity by state (IBS) 
over all SNPs [28]. A default set of 426,019 SNPs was used 
for further analysis, as recommended by Affymetrix. In the 
quality assurance screening, we flagged SNPs with genotype 
call rates ＜ 95%, minor allele frequencies ＜ 0.01, and SNPs 
showing deviation from Hardy-Weinberg equilibrium 
(HWE) at p ＜ 0.0000001. The final set of acceptable 
markers included 312,506 autosomal SNPs. Accuracy of the 
genotyping was calculated by Bayesian robust linear 
modeling using the Mahalanobis distance (BRLMN) 
algorithm [29].
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Chemistry and anthropometric measurements
Serum, separated from peripheral venous blood, was 
obtained from each participant after a 12-h fast and then 
stored at －70oC until analyzed. For anthropometric 
measurements, WC was measured on exposed waists 
midway between the lower rib and the iliac crest using a 
measuring tape. For difficult cases, WC was measured at 3 
cm above the navel. Weight and height were measured while 
participants were wearing light clothing. BMI was calculated 
as weight (kg) divided by height squared (m²). Both systolic 
and diastolic BP was measured after a 15-min rest. In 
addition, each participant was interviewed using a struc-
tured questionnaire to collect information on smoking and 
alcohol consumption as well as demographic characteristics, 
such as age, gender, and family and past history of clinical 
diseases. Cigarette smoking was classified into never 
smokers, ex-smokers, and current smokers. Alcohol con-
sumption was divided into nondrinkers and current drinkers. 
Regular physical activity was tracked as either “yes” or “no”. 
SNP selection and GRS calculation
In the association of SNPs with CRC, the SNPs with p ＜ 
10－5 in Korean men were: rs17391002 (CXCL12), rs9549448 
(SOX1), rs254833 (MYO10), rs2553614 (TMEM71), 
rs13153032 (NSUN2), rs2288073 (FLJ30851), rs9604214 
(SOX1), rs9865670 (OPA1), rs17186320 (KIAA1009), 
rs1509497 (RFX8), rs235428 (PHF20L1), rs9845920 
(OPA1), rs9846212 (OPA1), rs6763744 (OPA1), rs4128317 
(ALK), rs7646304 (OPA1), rs17047306 (SPATA17), 
rs1490338 (SPATA17), rs902351 (SPATA17), and 
rs2543662 (ITSN2) (Supplementary Table 1). The SNPs with 
p ＜ 10－5 in Korean women in the association between SNPs 
and CRC were: rs10083736 (GOT2), rs16987827 (DHX35), 
rs8046516 (GOT2), rs9926182 (GOT2), rs17523778 
(FAM174B), rs4974411 (TPRA1), rs1834902 (H2AFY), 
rs16895308 (MAST4), rs8032832 (FAM174B), rs6901560 
(PD6), rs11025480 (PRMT3), rs3814110 (BNC2), 
rs16895307 (MAST4), rs7089063 (MARCH8), rs16893688 
(IBTK), rs6861487 (MAST4), rs9613463 (MN1), rs11242237 
(H2AFY), rs11150094 (WWOX), and rs9625253 (MN1) 
(Supplementary Table 2). Each SNP in this study was 
assumed to be associated with risk according to an additive 
genetic model, which performs well, even when the true 
genetic model may not be known or may be incorrectly 
specified [30]. 
A GRS was calculated on the basis of reproducible tagging 
of SNP-associated loci reaching genomewide levels of 
significance. In this study, the GRS was calculated with the 3 
SNPs in Korean men and 5 SNPs in Korean women showing 
the strongest association with CRC (p ＜ 10－6). The GRS 
was created by two methods: a simple count method (count 
GRS) and a weighted method (weighted GRS) [31, 32]. Both 
methods anticipated each SNP to be independently 
associated with risk. We assumed an additive genetic model 
for each SNP, applying a linear weighting of 0, 1, or 2 to 
genotypes containing 0, 1, or 2 risk alleles, respectively. This 
model is known to perform well, even when the true genetic 
model is unknown or wrongly specified [30]. The count 
model assumes that each SNP in the panel contributes 
equally to the risk for CRC and was calculated by summing 
the values for each of the SNPs. The weighted GRS was 
calculated by multiplying each beta-coefficient by the 
number of corresponding risk alleles (0, 1, 2). 
Outcome classification
The principle outcome variables were prevalence (n = 
165) and incidence rates (n = 22), based on national cancer 
registry and hospitalization records. Although Korea has a 
national cancer registry, reporting was not complete during 
the time of follow-up, and consequently, hospital admission 
files were used to identify first admission events for CRC. An 
incident of CRC was coded as occurring, based on either a 
positive report from the national cancer registry or upon 
hospital admission for a cancer diagnosis [33]. According to 
the International Classification of Diseases, Tenth Revision 
(ICD-10), CRC was coded as C18-C20 [34]. 
Statistical analysis
All analyses were conducted using PLINK version 1.06 
(Free Software Foundation, Inc., Boston, MA, USA) and SAS 
statistical software version 9.0 (SAS Institute Inc., Cary, NC, 
USA). All statistical tests were two-sided, and statistical 
significance was determined as p ＜ 0.05. To evaluate general 
characteristics of the study population, means and standard 
deviations (SD) were calculated, and frequency of cigarette 
smoking, alcohol consumption, and physical activity was 
determined. Paired t-tests were performed to indicate the 
differences between case participants and control partici-
pants for both men and women. A X2 goodness-of-fit test 
was used to assess whether SNPs were in HWE and to 
determine differences in genotype frequencies between CRC 
cases and controls. The GRS was categorized into quartiles. 
The CRC risk associated with genotype was estimated as s 
ORs and 95% confidence interval (CI), computed using 
logistic regression with an additive genetic model. We also 
used receiver operating characteristic (ROC) curve analysis 
and calculated the area under the curve (AUC; also known as 
the C statistic) to evaluate the discrimination power of the 
model. In addition, internal validity of each model was 
checked using bootstrap [35], while 10-fold crossvalidation 
was used for the external validity of each model (Supple-
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　Variables
Men (n = 687)
p-value
Women (n = 476)
p-valueCase
(n = 133)
Control
(n = 554)
Case
(n = 54)
Control
(n = 422)
Age (y) 49.4 ± 7.7 42.1 ± 8.6 <0.0001 49.4 ± 7.2 41.0 ± 8.0 <0.0001
BMI (kg/m2) 24.6 ± 2.7 24.6 ± 2.9  0.882 23.2 ± 3.5 22.5 ± 3.0  0.149
WC (cm) 86.2 ± 7.2 85.6 ± 8.0  0.477 74.8 ± 9.2 75.0 ± 8.2  0.907
Systolic blood pressure (mm Hg) 122.9 ± 14.6 124.8 ± 12.2  0.119 117.7 ± 15.8 115.4 ± 13.8  0.267
Diastolic blood pressure (mm Hg)  77.4 ± 11.4  77.6 ± 32.8  0.969  74.0 ± 11.3 70.5 ± 9.8  0.010
Smoking status 
Never smokers 26.7 26.4 95.6 93.1
Ex-smokers 43.3 26.9 <0.0001  2.2  3.1 <0.0001
Current smokers 30.0 46.7  2.2  3.8
Alcohol consumption 
Yes 86.8 94.8  0.0004 28.3 65.8 <0.0001
Family history of colon cancer
Yes 11.3  2.2 <0.0001 11.1  2.1 0.0004
Values are presented as mean ± SD and percentage.
KCPS-II, Korean Cancer Prevention Study-II; BMI, body mass index; WC, waist circumference; SD, standard deviation.
Table 1. General characteristics of case participants and control participants in KCPS-II
Variables
Men Women
OR (95% CI) OR (95% CI)
Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4
Age (y)
<45 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
45-49 1.2 (0.7-2.1) 1.1 (0.6-2.0) 0.9 (0.5-1.7) 1.0 (0.5-1.8) 0.2 (0.1-0.4) 0.1 (0.1-0.4) 0.3 (0.1-0.8) 0.3 (0.1-0.9)
50-54 2.7 (1.7-4.2) 2.5 (1.6-3.9) 2.4 (1.4-4.0) 2.4 (1.4-4.0) 0.8 (0.5-1.4) 0.8 (0.4-1.4) 1.3 (0.6-2.6) 1.3 (0.7-2.7)
≥55 6.6 (4.4-9.9) 6.1 (4.1-9.1) 6.2 (3.8-10.1) 6.3 (3.9-10.2) 2.0 (1.3-3.1) 1.9 (1.2-3.0) 3.6 (2.0-6.7) 3.6 (2.0-6.6)
Family history of CRC
Yes - 4.5 (2.0-10.3) 4.3 (1.9-10.1) 4.0 (1.7-9.3) - 4.0 (1.3-12.2) 4.6 (1.4-15.7) 4.6 (1.4-15.3)
Counted GRS
Q1 - - - - - - - -
Q2 - - 0.7 (0.4-1.1) - - - 0.3 (0.1-0.5) -
Q3 - - 1.7 (1.0-2.8) - - - 0.3 (0.1-0.6) -
Q4 - - 6.6 (2.9-14.8) - - - 2.0 (0.9-4.1) -
Weighted GRS
Q1 - - - - - - - -
Q2 - - - 0.6 (0.4-1.0) - - - 0.2 (0.1-0.5)
Q3 - - - 1.3 (0.8-2.2) - - - 0.4 (0.2-0.8)
Q4 - - - 2.7 (1.6-4.6) - - - 0.8 (0.4-1.5)
AUC
 (95% CI)
0.687 
(0.647-0.729)
0.692
(0.647-0.732)
0.729
(0.682-0.767)
0.719
(0.677-0.761)
0.598
(0.564-0.628)
0.603
(0.569-0.637)
0.650
(0.615-0.680)
0.646
(0.612-0.674)
KCPS-II, Korean Cancer Prevention Study-II; OR, odds ratio; CI, confidence interval; CRC, colorectal cancer; GRS, genetic risk score; 
AUC, area under the curve.
Table 2. Odds ratios and 95% confidence intervals for colorectal cancer using counted and weighted genetic risk score in Korean
men and women in KCPS-II
mentary Tables 3 and 4) [36]. 
Results
Our analysis included 687 men (cases, 133; controls, 554) 
and 476 women (cases, 54; controls, 422), 20-77 years of 
age. The number of prevalent cases of CRC identified was 
166. An additional 22 incident cases of CRC occurred during 
follow-up. Table 1 details the general characteristics of case 
participants and control participants at baseline. The mean 
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Fig. 1. Effects of family history of 
CRC and GRS on the risk of CRC
in Koreans who participated in the 
KCPS-II (adjusted for age, BMI and
smoking status) (A) counted GRS 
in men and women (B) weighted 
GRS in men and women. CRC, 
colorectal cancer; GRS, genetic 
risk scores; KCPS-II, Korean 
Cancer Prevention Study-II; BMI, 
body mass index; OR, odds ratio.
aMeans statistically significant.
age (SD) was 42.9 (± 8.7) years for the study popu-
lation-43.5 (± 8.9) for men and 42.0 (± 8.4) for women, 
respectively. No significant differences were observed in 
BMI, WC, systolic BP, or diastolic BP among case participants 
and control participants for both men and women (p ＞ 
0.05); however, case participants were older and had a family 
history of CRC more than control participants in both men 
and women (p ＜ 0.001). 
Table 2 indicates the area under the ROC curves for 
models that included both conventional risk factors and a 
genetic risk factor, GRS, compared with the AUC for the 
model that included only conventional risk factors. In the 
prediction model of CRC, we included age and family history 
of CRC as conventional risk factors and counted GRS or 
weighted GRS as genetic risk factors. For both men and 
women, including the GRS in the model increased the AUC 
over that observed when the AUC was based on only age or 
age and family history of CRC. For men, the AUC (95% CI) 
was 0.729 (range, 0.682 to 0.767) for conventional risk 
factors plus counted GRS (p ＜ 0.001) and 0.719 (range, 
0.677 to 0.761) for conventional risk factors plus weighted 
GRS (p ＜ 0.001). The AUC (95% CI) was 0.692 (range, 
0.647 to 0.732) for conventional risk factors alone. The 
increase in the AUC for the model with counted GRS was 
0.042 and 0.032 for the model with weighted GRS. For 
women, the AUC (95% CI) was 0.650 (range, 0.615 to 
0.680) for conventional risk factors plus counted GRS (p ＜ 
0.001) and 0.646 (range, 0.612 to 0.674) for conventional 
risk factors plus weighted GRS (p ＜ 0.001). The AUC (95% 
CI) was 0.603 (range, 0.569 to 0.637) for conventional risk 
factors alone. The increase in the AUC for the model with 
counted GRS was 0.052 and 0.048 for the model with 
weighted GRS. 
We further examined the association between GRS and 
CRC risk for both men and women in the KCPS-II, with 
stratification by family history of CRC (Fig. 1). The 
interaction between counted or weighted GRS and family 
history of CRC was significant in men, indicating a stronger 
genetic effect among participants with a positive family 
history of CRC than in those without it (p for interaction ＜ 
0.05) (ROC, 0.834 for counted GRS; ROC, 0.822 for 
weighted GRS). Women with a positive family history of 
CRC in the highest quartile of weighted GRS had an OR of 
22.3 (95% CI, 1.4 to 344.2) and 18.1 (95% CI, 3.7 to 88.1) 
compared to those without a family history of CRC and 
counted or weighted GRS in the lowest quartile, respectively 
(ROC = 0.826 for counted GRS; ROC = 0.818 for weighted 
GRS). However, they were not statistically significant (p for 
interaction ＞ 0.05). In addition, smoking, alcohol con-
sumption, BMI, and WC did not interact significantly with 
GRS (data not shown). 
Discussion
This study evaluated the ability of the GRS, which 
aggregates information from multiple genetic variants, to 
improve the prediction of CRC risk beyond the prediction 
risk afforded using conventional risk factors. For both men 
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and women, inclusion of counted GRS or weighted GRS 
increased the AUC by 0.5% to 4.2% beyond the AUC 
provided by conventional risk factors, such as age and family 
history of CRC. Men with a positive family history of CRC 
and GRS in the highest quartile were determined to have a 
statistically significant increased risk of CRC than those 
without a family history of CRC and GRS in the lowest 
quartile. However, women with a positive history of CRC 
and GRS in the highest quartile were determined to have an 
increased risk of CRC than those without a family history of 
CRC and GRS in the lowest quartile, but this result was not 
statistically significant. 
CRC is a multifactorial disease involving a variety of 
elements, leading to the development of clinical mani-
festations [37]. This recognition had led to the development 
of risk assessment tools that attempt to synthesize the 
values of numerous variables into a single statement 
regarding the risk of developing cancer [38]. In this study, 20 
SNPs were respectively genotyped in Korean men and 
women. Among these SNPs, 3 SNPs in Korean men and 5 
SNPs in Korean women showing the strongest association 
with CRC were used for the calculation of GRS. The GRS was 
calculated using a linear weighting of 0, 1, or 2 for genotypes 
containing 0, 1, or 2 risk alleles, respectively. The weighted 
GRS was computed by multiplying each beta-coefficient by 
the number of corresponding risk alleles. However, when 
multiplying each beta-coefficient by the number of cor-
responding risk alleles, negative values of beta-coefficients 
may be obtained in some genotypes of the SNPs. Therefore, 
it may affect the OR values for CRC when compared to the 
OR values for CRC determined using counted GRS. Still, the 
calculation results of both counted GRS and weighted GRS 
were similar to each other.
Cornelis et al. [31] and Ripatti et al. [32] used methods 
similar to the GRS created for our study. Several other 
studies have reported different ways of calculating risk 
scores for the prediction of diseases [39-41]. Horne et al. 
[39] introduced a regression method for calculating risk 
scores that incorporated 3 genetic polymorphisms and other 
risk factors and found that the frequency of coronary heart 
disease was different at different regression score levels. 
Ortlepp et al. [40] concluded that multiple SNPs are better 
than single SNPs and that as many as 200 SNPs may be 
necessary for “reasonable” genetic discrimination. Aston et 
al. [41] suggested that a score based on 90 SNPs in 78 genes 
can predict the risk of breast cancer, but the identity of the 
SNPs and the algorithm for calculating the score remain 
proprietary. An alternative way to calculate GRS using 
machine approaches, such as support vector machines 
(SVMs), could be introduced, as SVMs have already been 
used to deal with many biological problems, such as DNA 
expression profiles [42]. Still, further studies are needed to 
use machine learning approaches, such as SVMs, for the 
calculation of GRS. To our knowledge, there have been no 
studies evaluating a GRS using SNPs contributing to CRC for 
the prediction of the disease in the Korean population. 
The present study evaluated a prediction model using 
counted GRS or weighted GRS together with conventional 
risk factors, such as age and family history of CRC among 
Koreans. The risk of CRC is said to increase in individuals 
with a family history of CRC, in particular those ＞50 years 
of age [43, 44]. From a recent study, a CRC prediction model 
was developed with known major risk factors of age, BMI, 
alcohol consumption, smoking status, and physical activity 
level for middle-aged Japanese men [17]. Another recent 
study on the prediction model of CRC included an indi-
vidual’s age, sex, history of CRC, sigmoidoscopy/colono-
scopy, polyps, family history of CRC, smoking, physical 
activity, aspirin/NSAID use, vegetable intake, BMI, and 
hormone replacement in women [16]. In our study, the 
prediction model of CRC was comprised of conventional risk 
factors, such as age and family history of CRC, together with 
the GRS. As determined, inclusion of counted GRS or 
weighted GRS revealed improved estimates of CRC 
prediction beyond that provided by conventional risk factors, 
such as age and family history of CRC. For example, when 
counted GRS were added to the prediction model of CRC 
consisting of age and family history of CRC, the AUC 
increased by 4.2% in men and 5.2% in women, whereas the 
AUC increased by 3.2% in men and 4.8% in women when 
weighted GRS were added to the same model. Studies 
showing significant relationships of GRS in conjunction 
with coronary heart disease, type 2 diabetes, and breast 
cancer have reported that considering the contribution of 
multiple SNPs may improve the predictive value of GRS for 
such diseases [18, 31, 45]. In other words, combining 
multiple loci with modest effects into a global GRS might 
improve identification of persons who are at risk for such 
diseases [23-25]. For example, in the ARIC study, the 
contribution of multiple SNPs into a single GRS was 
responsible for an improvement in the prediction of incident 
CHD [18]. In a study that used counted GRS or weighted 
GRS to determine the risk for type 2 diabetes in US men and 
women, individuals in the highest quintile of GRS had a 
significantly increased risk of type 2 diabetes compared to 
those in the lowest quintile; however, the addition of GRS 
increased the AUC by only 1%. In this instance, the GRS was 
determined to be useful when combined with the joint 
effects of BMI and counted GRS or family history of diabetes 
and counted GRS [30]. In our study, individuals in the 
highest quartile of GRS had increased risk of CRC compared 
to those in the lowest quartile of GRS for both men and 
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women. In addition, in strata of family history of CRC and 
GRS, this increase was even higher in individuals with a 
family history of CRC in the highest quartile of GRS 
compared to those without a family history of CRC in the 
highest quartile of GRS in both men and women. Still, there 
were statistically significant interactions in men but not in 
women. In this study, the most commonly used conventional 
risk factors, such as smoking and alcohol consumption, were 
also not included in the prediction model of CRC, as 
smoking, alcohol consumption, BMI, and WC did not 
significantly interact with the GRS. Therefore, further 
studies are needed to verify these results. 
A family history of CRC is commonly used as a surrogate 
marker for determining genetic susceptibility to CRC and 
remains one of the strongest risk factors for the disease [10, 
31, 46]. Approximately 25% of all CRC cases occur in 
individuals with a family history of the disease and no 
genetic disorders [47]. In addition, some retrospective 
studies have suggested that a history of CRC in a first-degree 
relative (a parent or sibling) elevates a person’s lifetime risk 
of CRC from 1.8-fold to 8.0-fold [10, 47]. This family history 
risk factor may encompass both genetic and shared environ-
mental components [31]. In our study, after controlling for 
age and GRS, the strong relationship between family history 
of CRC and risk of CRC persisted. These findings suggest 
that other risk loci remain to be discovered or that family 
history has a much larger shared environmental component 
than previously thought [31].
Our study was not without limitations. The cross- 
sectional design precluded the determination of causality, 
and a prevalent case bias may exist due to the higher number 
of prevalent cases (n = 165) of CRC included compared to 
the number of incident cases (n = 22). Combining pre-
valence and incidence cases could introduce survival biases. 
Still, the 5-year survival rate for CRC in Koreans was 71.3% 
in 2009 while that in Americans, Europeans, and Japanese 
was 65.0%, 56.2%, and 65.2%, respectively [43]. It could be 
said that Koreans have higher survival rates for CRC 
compared to other ethnic populations. Additionally, this 
study is also a case-cohort study. Blood samples of prevalent 
cases used in this study were from baseline, and incidence 
cases during the follow-up period, suggested as prevalent 
cases in this study, might have been missed, as other blood 
samples were not taken. Therefore, those prevalent cases at 
baseline might have become incident cases or mortality 
cases during the follow-up period. It is hard to say if this 
study was performed among survivors. Another limitation 
included a self-reported family history of CRC, thus 
precluding the definitive exclusion of potential misclassi-
fications. The statistical power of the current study might be 
too low, as genotyping was performed separately for men and 
women. In addition, performing multiple tests separately in 
both men and women may increase error rates. Although 
CRC affects men and women equally, gender differences in 
CRC may exist. For example, regarding colorectal polyps and 
tumors, men had a greater risk of polyps (OR, 1.52; 95% CI, 
1.41 to 1.64) and tumors (OR, 1.43; 95% CI, 1.22 to 1.68) 
than women. In addition, women had greater number of 
purely right-sided polyps and tumor development [48]. 
Therefore, detection of genetic effects separately in men and 
women may be needed. In addition, age differences in case 
and control participants may also increase error rates, as 
control participants may become CRC patients when they 
reach the case age. This study also involved the lack of 
validation and replication of the current study results. 
Therefore, it is hard to say that there may have been a true 
association between GRS and CRC in Korean men and 
women. However, bootstrapping and 10-fold cross valida-
tion were used for internal and external validity of this 
current study. Furthermore, although sigmoidoscopy/ 
colonoscopy history was the strongest risk factor in the 
previous study, this current study did not include it as one of 
the conventional risk factors of CRC. Cases included in this 
study were also relatively small. This study also excluded 
cases ≥ 55 years of CRC onset age to obtain early-onset CRC 
cases. Therefore, estimate effects of cases ≥ 55 years of CRC 
onset age were hard to be seen in this study. Finally, most 
SNPs found to be associated with CRC among the study 
population were not similar to those SNPs found in relation 
to CRC among other populations. It also could be due to 
differences in ethnic population and the ages of case 
participants included in this study (cases ＜ 55 years). 
Nevertheless, this relatively large-scale study demonstrated 
the effectiveness of the prediction model of CRC using the 
GRS consisting of only SNPs that associated significantly 
with CRC and evaluated the effects on the risk for CRC in 
combination with conventional risk factors, such as family 
history of CRC, with the GRS. Moreover, the present study 
included the Korean population, whereas previous studies 
involving CRC prediction models using conventional risk 
factors or the relationship of genetic risk factors to CRC were 
limited to white and Japanese populations [17, 20-22]. 
In conclusion, our findings suggest that the prediction 
model of CRC revealed improved prediction estimates when 
age, family history of CRC, and the GRS in the Korean 
population were included. Furthermore, when compared to 
those in the lowest quartile of GRS in the presence or 
absence of a family history of CRC, the risk of CRC was 
found to be significantly increased in individuals with a 
family history of CRC in the highest quartile of GRS. 
However, it was statistically significant in men but not in 
women. Findings in this current study might provide a small 
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piece of evidence in prediction of CRC for reducing its 
prevalence and incidence rates. The prediction model 
developed in this study needs to be validated or replicated in 
an independent population. Therefore, further studies are 
needed to be applied to the general population. 
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